| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 7.1e-05 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -7.6e-05 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -6.9e-05 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 4.8e-05 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 1.1e-05 | 1 |